Advanced Cancer Therapeutics
Strategies and Technologies for Targeted Drug Delivery
- 1st Edition - May 1, 2026
- Latest edition
- Editors: Manish Kumar, Abhishek Jha, Brahmeshwar Mishra
- Language: English
Advanced Drug Delivery Systems for Targeted Cancer Therapy explores the heterogeneity of tumors and microenvironmental factors that influence cancer treatment and contribute to dru… Read more
Purchase options
Advanced Drug Delivery Systems for Targeted Cancer Therapy explores the heterogeneity of tumors and microenvironmental factors that influence cancer treatment and contribute to drug resistance. It discusses critical elements such as tumor stroma, vasculature, pH, hypoxia, and enzymatic activity that impact therapeutic efficacy. The book covers advanced drug formulations, including supramolecular systems, metal-organic frameworks, and nanomedicine, focusing on their roles in selective drug delivery for early detection, diagnosis, and treatment of various cancers. It reviews the current status and future perspectives of these formulations, highlighting their potential to enhance therapeutic outcomes while minimizing side effects. Additionally, it examines the limitations of nanocarriers and addresses regulatory and ethical considerations related to anticancer formulations. This resource is invaluable for researchers, clinicians, and students, offering insights into the latest advancements in drug delivery systems. It bridges the gap between conventional and innovative therapies, equipping the audience with essential knowledge for developing precise cancer treatment strategies.
- Presents an extensive examination of various advanced drug formulations, including nanomedicine, supramolecular systems, and metal-organic frameworks, highlighting their roles in targeted cancer therapy
- Emphasizes the significance of the tumor microenvironment and heterogeneity in influencing drug resistance, providing insights into how these factors affect therapeutic efficacy and treatment outcomes
- Analyzes the limitations of current drug delivery systems, discusses regulatory considerations, and explores future perspectives in anticancer drug delivery
Researchers in the fields of pharmaceutical sciences, oncology, and drug delivery systems
I. UNDERSTANDING THE CANCER
1. Introduction to cancer
2. Current practices in cancer chemotherapy
3. Emerging trend in anticancer drug delivery
4. Cancer therapy depending on tumor stroma
5. Cancer therapy depending on cancer cell respiration: pH and hypoxia
6. Cancer therapy depending on tumor vasculature and EPR effects.
7. Cancer therapy based on extracellular matrix
8. Heterogenicity of cancer and drug resistance
II. STRATEGIES AND TECHNOLOGIES FOR CANCER THERAPY
9. Materials and strategies for advanced anticancer drug delivery
10. Drug Conjugates for anticancer drug delivery
11. Microparticles for anticancer drug delivery
12. Self-assembled supramolecular systems for anticancer drug delivery
13. Advances in metal-organic frameworks for anticancer drug delivery
14. Nanotechnology for anticancer drug delivery: possibilities and limitations
15. Tumor microenvironment targeted drug delivery systems
16. Advances in dendrimers for anticancer drug delivery
17. Advances in metallic nanoparticles for anticancer drug delivery
18. Advances in polymeric nanoparticles for anticancer drug delivery
19. Advances in lipid-based nanoparticles for anticancer drug delivery
20. Advances in SNEDDS for anticancer drug delivery
21. Advances in nanocrystals for anticancer drug delivery
22. Theranostic nanoparticles for advanced cancer therapy
23. Advances in hydrogel for anticancer drug delivery
24. Nanofibrous scaffolds for cancer management
25. Genetic nanomaterials for anticancer drug delivery
26. Organic nanocarriers for anticancer drug delivery
27. Microneedles for anticancer drug delivery
28. Implants for anticancer drug delivery
29. Phytoconstituents based anticancer drug delivery systems
III. CLINICAL STATUS, CHALLENGES AND FUTURE PROSPECTIVES
30. Clinical status of anticancer drug delivery systems
31. Challenges and future prospectives in anticancer drug delivery
32. Regulatory considerations for anticancer drug delivery systems
1. Introduction to cancer
2. Current practices in cancer chemotherapy
3. Emerging trend in anticancer drug delivery
4. Cancer therapy depending on tumor stroma
5. Cancer therapy depending on cancer cell respiration: pH and hypoxia
6. Cancer therapy depending on tumor vasculature and EPR effects.
7. Cancer therapy based on extracellular matrix
8. Heterogenicity of cancer and drug resistance
II. STRATEGIES AND TECHNOLOGIES FOR CANCER THERAPY
9. Materials and strategies for advanced anticancer drug delivery
10. Drug Conjugates for anticancer drug delivery
11. Microparticles for anticancer drug delivery
12. Self-assembled supramolecular systems for anticancer drug delivery
13. Advances in metal-organic frameworks for anticancer drug delivery
14. Nanotechnology for anticancer drug delivery: possibilities and limitations
15. Tumor microenvironment targeted drug delivery systems
16. Advances in dendrimers for anticancer drug delivery
17. Advances in metallic nanoparticles for anticancer drug delivery
18. Advances in polymeric nanoparticles for anticancer drug delivery
19. Advances in lipid-based nanoparticles for anticancer drug delivery
20. Advances in SNEDDS for anticancer drug delivery
21. Advances in nanocrystals for anticancer drug delivery
22. Theranostic nanoparticles for advanced cancer therapy
23. Advances in hydrogel for anticancer drug delivery
24. Nanofibrous scaffolds for cancer management
25. Genetic nanomaterials for anticancer drug delivery
26. Organic nanocarriers for anticancer drug delivery
27. Microneedles for anticancer drug delivery
28. Implants for anticancer drug delivery
29. Phytoconstituents based anticancer drug delivery systems
III. CLINICAL STATUS, CHALLENGES AND FUTURE PROSPECTIVES
30. Clinical status of anticancer drug delivery systems
31. Challenges and future prospectives in anticancer drug delivery
32. Regulatory considerations for anticancer drug delivery systems
- Edition: 1
- Latest edition
- Published: May 1, 2026
- Language: English
MK
Manish Kumar
Manish Kumar holds the position of Assistant Professor at Amity Institute of Pharmacy in the Greater Noida Campus of Amity University. He completed his doctoral degree at the Indian Institute of Technology (Banaras Hindu University), Varanasi-221005, India. He possesses over 8 years of academic research experience. His research interests are controlled drug delivery systems, nanoemulsions, polymeric nanoparticles, lipid nanoparticles, nanocrystals, nanofibrous scaffolds, hydrogel, and microneedles for treating cancer, wounds, and inflammatory diseases. To date, he has authored over 40 peer-reviewed articles and more than 25 book chapters that have been published in well-known international journals
Affiliations and expertise
Amity University, IndiaAJ
Abhishek Jha
Abhishek Jha is an Assistant Professor at the Department of Pharmaceutics, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pune, Maharashtra. He did his Ph.D. and M.Pharm from the Indian Institute of Technology (Banaras Hindu University), India. He has more than 8 years of professional experience in academic research. His field of research includes the development of novel drug delivery technologies for controlled, targeted, and localized delivery of therapeutics for various ailments, including but not limited to cancer, wounds, and inflammatory diseases. So far he has contributed in more than dozens of peer-reviewed articles and more than 25 book chapters published in reputed international journals.
Affiliations and expertise
Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, IndiaBM
Brahmeshwar Mishra
Dr. Brahmeshwar Mishra is a Professor of Pharmaceutics at the Indian Institute of Technology (BHU) in Varanasi, with over 40 years of experience in teaching and research. He has served as the Chairman of the Medical Board at IIT (BHU) from June 2012 to 2023. His expertise lies in the formulation of controlled and novel drug delivery systems, including nanoformulations, focusing on bioavailability and pharmacokinetics. He has supervised over 30 doctoral candidates and nearly 100 postgraduate students, publishing around 300 articles, 226 abstracts, 43 book chapters, and holding 3 patents.
He is a leading researcher in drug delivery. He has received numerous awards, including the Best Young Pharmacy Teacher Award and the Pharmacy Excellence Award. Additionally, he has served on editorial boards, traveled internationally for talks, and participated in various academic committees and programs.
Affiliations and expertise
Indian Institute of Technology (BHU), India